United Therapeutics
UTHR
$235.95
Share price
-0.44%
Change (1 day)
4.26%
Change (1 year)
Categories
United Therapeutics (UTHR) - Net assets
Net assets on the balance sheet as of December 2023 : $5.98 B
According to United Therapeutics's latest financial reports the company has $5.98 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
United Therapeutics - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $5.98 B | 24.77% |
| 2022-12-31 | $4.79 B | 21.16% |
| 2021-12-31 | $3.95 B | 16.6% |
| 2020-12-31 | $3.39 B | 22.11% |
| 2019-12-31 | $2.78 B | -0.98% |
| 2018-12-31 | $2.80 B | 32.38% |
| 2017-12-31 | $2.12 B | 13.9% |
| 2016-12-31 | $1.86 B | 16.41% |
| 2015-12-31 | $1.59 B | 26.4% |
| 2014-12-31 | $1.26 B | -2.97% |
| 2013-12-31 | $1.30 B | 19.13% |
| 2012-12-31 | $1.09 B | 14.12% |
| 2011-12-31 | $0.95 B | 8.54% |
| 2010-12-31 | $0.88 B | 35.36% |
| 2009-12-31 | $0.65 B | 17.59% |
| 2008-12-31 | $0.55 B | 87.75% |
| 2007-12-31 | $0.29 B | 44.57% |
| 2006-12-31 | $0.20 B | -25.63% |
| 2005-12-31 | $0.27 B | 43.55% |
| 2004-12-31 | $0.19 B | 14.23% |
| 2003-12-31 | $0.16 B | -2.27% |
| 2002-12-31 | $0.17 B | -12.6% |
| 2001-12-31 | $0.19 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $89.28 B | 1,391.91% | 🇺🇸 USA |
 Eli Lilly LLY | $10.86 B | 81.52% | 🇺🇸 USA |
 Baxter BAX | $8.46 B | 41.49% | 🇺🇸 USA |
 Gilead Sciences GILD | $22.74 B | 280.11% | 🇺🇸 USA |
 Cardinal Health CAH | -$3.45 B | -157.60% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $16.28 B | 172.16% | 🇬🇧 UK |
 Cytokinetics
CYTK | -$0.39 B | -106.46% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $8.12 B | 35.78% | 🇮🇱 Israel |